ISSN: 1859 - 2872
Determining the mortality prognostic value of cytokine storm score in hospitalized COVID-19 patients
Main Article Content
Keywords
Abstract
Objective: To determine the mortality prognostic value of the cytokine storm score (CSs) in hospitalized COVID-19 patients. Subject and method: A prospective study, longitudinal follow-up of 81 COVID-19 patients admitted to the COVID-19 Treatment Center, 175 Military Hospital from August 2021 to October 2021. The cytokine storm score was applied to predict mortality risk. Result: There were 81 COVID-19 patients included in the study, with a mean age of 55.67 ± 14.6 years. Men were 45.7% and women were 54.3%. Positive of CSs accounted for 54.32%. CSs scores were higher in severe COVID-19 patients. The CSs score had a good predictive ability of mortality in COVID-19 patients, with an area under the ROC curve was 0.95. The best cutoff value for predicting mortality was CSs ≥ 4 points, with sensitivity 96.55%, specificity 82.69%, positive predictive value 75.67%, negative predictive value 97.72%. Conclusion: The CSs score was an effective tool to predict mortality risk for hospitalized COVID-19 patients.
Article Details
References
2. Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C, Andreani P, Mariottini A, Francucci M, Sensi E, Costantini M, Bruzzone P, D'Andrea V, Gioia S, Cirocchi R, Tiri B (2021) When does the cytokine storm begin in COVID-19 patients? A quick score to recognize it. J Clin Med 10(2): 297. doi: 10.3390/jcm10020297.
3. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58(5): 377-382.
4. Guo J, Zhou B, Zhu M, Yuan Y, Wang Q, Zhou H, Wang X, Lv T, Li S, Liu P, Yang Y, He P, Zhang P (2020) CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: A retrospective cohort study. Epidemiol Infect 148: 241.
5. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 8(5): 475-481.
6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395(10229): 1054-1062.
7. Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R, Ghasemnejad T (2022) COVID-19 infection: An overview on cytokine storm and related interventions. Virol J 19(1): 92. doi: 10.1186/s12985-022-01814-1.
8. Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the “Cytokine Storm” in COVID-19. J Infect 80(6): 607-613.
9. Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L (2020) Interleukin-6 as prognosticator in patients with COVID-19. J Infect 81(3): 452-482.
10. Nguyễn Minh Thế, Dương Minh Chiến, Vũ Đức Hiếu, Hoàng Thị Phong Lan & Nguyễn Hải Công (2021) Xác định giá trị tiên lượng tử vong của thang điểm CURB-65 ở bệnh nhân viêm phổi do COVID-19 nhập viện. Tạp chí Y Dược lâm sàng 108, 16(8).
Article Sidebar
